Latest Managed Care News

CVS Health plans to separate its healthcare solutions and retail pharmacy businesses by the first half of 2028, while raising its 2026 earnings and cash-flow targets. The announcement came alongside stronger third-quarter results, though management flagged elevated cost trends and potential macroeconomic pressure.

SomnoMed reported a 3% revenue rise to $114.5 million and a 19% EBITDA increase to $10.9 million in FY26, navigating European market headwinds and a CEO transition while launching its Virtus device targeting sleep apnea with bruxism.

Locate Technologies’ Q4 FY26 update highlights a 54% surge in Locate2u revenue to NZ$1.20 million, driving normalised EBITDA into positive territory. AI integration accelerated product development and customer onboarding, while capital moves included a share buyback and royalty conversion.

Singular Health has received a US$500,000 payment from Provider Network Solutions following the deployment of an additional 500 3DICOM MD® licenses, marking progress in commercial adoption and cost-saving benefits within a major US healthcare network.

Singular Health Group reported a 55% rise in net loss to $2.97 million for H1 FY2026, driven by share-based payments and strategic hires, while making significant progress in US commercial deployments and securing FDA clearance for its cloud-based 3D medical imaging platform.

Breville Group Limited has reported a record half-year revenue of $1.1 billion for the six months ended December 2025, alongside modest profit growth and a raised interim dividend.

AXP Energy reports encouraging early oil and gas flowback at its Charlie #1 well in Oklahoma, marking a key milestone in its Mississippi Lime development program.

Recharge Metals Limited has progressed its uranium exploration efforts in North America, completing a detailed geophysical survey in Canada and advancing permitting in the US, while maintaining disciplined capital management.

Singular Health Group has advanced its US expansion through the deployment of 3DICOM™ licenses under a key contract with Provider Network Solutions, alongside appointing a new US commercial chief to drive growth.

SomnoMed delivered a strong FY25 performance with revenue climbing 22% to $111.5 million and EBITDA turning positive at $9.2 million, boosted by operational improvements and FDA clearance of its Rest Assure device. The company projects further growth in FY26 with expanded manufacturing and ongoing innovation.

Earlypay Limited reported a 24% rise in underlying NPAT and a 30% increase in EPS for FY25, driven by strong growth in Equipment Finance that offset declines in Invoice and Trade Finance portfolios.

Novo Resources Corp reported a reduced net loss of CAD 5.85 million for H1 2025, improving liquidity while continuing its gold exploration efforts in Australia.